News
The patient succumbed to the deadly virus at a private hospital in Perinthalmanna. His test results returned Nipah positive ...
Kerala, which first reported Nipah outbreak in 2018, has recorded four cases this year so far, of which two have died, one recovered and the other is undergoing treatment.
The global sepsis diagnostics market size was US$ 570 million in 2021. The global sepsis diagnostics market size is forecast to reach US$ 1,111.26 million by 2030, growing at a compound annual growth ...
Bonus Biogroup (TASE: BONS), a late-stage biotechnology company priming immunomodulatory and regenerative mesenchymal stem cells (MSC) to develop novel tissue engineering and cell therapy solutions, ...
Surveillance and medical protocols are in place, but environmental factors for the epidemic reappearing regularly cannot be ruled out.
Measurements The primary outcome measure was a composite endpoint of the incidence of acute respiratory distress syndrome, postoperative pulmonary ... of surgery or hospital discharge if earlier (3) ...
Three De-suup trainees, a man and two women, have died at the national referral hospital after a Leptospirosis outbreak at a ...
Objective To determine whether neuromuscular blocking agents (NMBAs) can decrease the mortality of patients with acute respiratory distress syndrome (ARDS) and improve their clinical outcomes. Design ...
India Today on MSN23d
From headache to hospitalization: How seasonal flu has changed post-COVIDA previously healthy people may develop myocarditis (inflammation of the heart tissue), pneumonia, acute respiratory distress syndrome (ARDS), and in certain situations, multi-organ dysfunction.
BioAegis will also have U.S. biologics exclusivity and has recently filed new IP in areas of unmet need. BioAegis’ lead product, rhu-pGSN, is currently being studied in a 600-patient global Phase 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results